Archive

Kentucky Medical Cannabis Licensing Update: New Bill and Regulations

By Yolanda Clarke, Colleen Mitchell
Apr 19, 2024

In an exciting week for the nascent Kentucky medical cannabis program, interested stakeholders were provided abundant new information to inform their business goals. Read this article for details on the new bill and regulations, and key licensing details—including medical cannabis business license caps.

Missouri Updates and New Licensing Opportunities

By Colleen Mitchell
Feb 14, 2024

Missouri's cannabis market is expanding rapidly, offering a new opportunity for microbusinesses. The state plans to issue 48 microbusiness licenses in summer 2024, allowing smaller players to enter the cultivation, processing, and dispensary sectors. However, applications are competitive and require careful preparation, including team building, business formation, and real estate acquisition. This Insights post provides key details about the licensing process and eligibility criteria.

[Webinar] Mississippi Medical Cannabis Update

Nov 16, 2023

Watch this Vicente LLP live session replay regarding Mississippi's medical cannabis market. Panelists will discuss the latest happenings in Mississippi’s cannabis market, business licensing application requirements, operational compliance within a cannabis business, and the future of the state’s growing industry.

Mississippi Medical Cannabis Market Update

By Colleen Mitchell, Andrew Livingston
Sep 20, 2023

It has been over a year since Mississippi began accepting applications for medical cannabis business licenses and the market has steadily grown. Now, with the residency requirement gone and the passing of a new bill that made some positive changes to the program, it is an excellent time to enter this budding market. Read this article for market updates, including the number of patients, dispensaries, cultivators and processors, in addition to new opportunities created by House Bill 1158.

Forming Psychedelic Companies: 10 Lessons from the Cannabis Industry

By Charles Alovisetti
Mar 22, 2023

A new industry is emerging in the United States, and entrepreneurs in the psychedelics space must make critical decisions at the onset of new ventures regarding how to set up and structure their new businesses. Luckily, we have access to another industry with a complex legal framework and a patchwork of different state laws: cannabis. And after forming hundreds of cannabis companies with clients over the past decade, Vicente LLP has lessons to be shared.

The Natural Medicine Health Act of 2022: A Measure to Access Psychedelic Medicine in Colorado

By Colleen Mitchell, Yolanda Clarke
Oct 10, 2022

Prop 122 would create a regulated system for adults aged 21 and older to access natural psychedelic medicine, such as psilocybin, in a supervised setting to treat various mental health conditions. It would also allow for the cultivation, possession, personal use, and gifting of psychedelic medicine for adults aged 21 and older. Read this for an overview of the proposition’s key components.

The ESG Threat by Shareholders and Proxy Challenges

By Marc Ross
Sep 7, 2022

Socially responsible investors and activist board members have been throwing their ESG weight around during the last few proxy seasons at annual shareholder meetings. They demand action on climate change, diverse boards and senior leadership, restrict campaign donations, divestment in specific industries, and request measurement, benchmarking, and reporting of comprehensive ESG impacts.

ABA Global Business of Cannabis Conference is Coming to Denver

Nov 9, 2021

The American Bar Association's International Law Section will host its first annual Global Business of Cannabis Conference in Denver, Colorado from November 10-12, 2021. Marc Ross is slated to join the panel "The Environmental Impact of Cannabis Cultivation: Does Legalization Make a Difference?"

The Battle to Allow Smokable Hemp in Texas

By Shane Pennington
Sep 13, 2021

Texas has allowed hemp cultivation and state-based manufacturing, distribution, and retail sale of hemp and consumable hemp products since 2019—but only if the products weren’t intended for smoking. This prohibition on a product with such high value for hemp farmers—and soaring consumer demand—was sure to make waves.

sxsw

Aug 25, 2021

Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!

Psychedelics As Medicine: Right To Try Case Versus DEA

By Shane Pennington
Aug 9, 2021

In what could be a groundbreaking case for psychedelic medicine, VS counsel Shane Pennington is part of a team working on an exciting and very important Ninth Circuit challenge to the DEA's refusal to accommodate state and federal right to try laws.

[Webinar] Impact and ESG in the Cannabis Industry

Jun 15, 2021

Watch this recorded session to meet the new VS Impact & ESG team, learn more about this emerging business priority, and how to start planning and measuring your ESG practice – including Corporate Social Responsibility programs, meaningful Diversity, Equity & Inclusion efforts, environmental sustainability, and community and employee engagement.

Litigation Funding for Cannabis and Hemp Businesses

By Jennifer Cabrera, David Kramer
Nov 30, 2020

As anyone who has been involved in a legal dispute knows, litigation can be very costly. Thankfully, litigation funding is an option and lenders are increasingly willing to lend to cannabis and hemp businesses.

Cannabis Litigation vs. Arbitration

By Jennifer Cabrera
Nov 20, 2020

While it’s best to avoid litigation and arbitration in the first place, disputes happen and are occurring more frequently in the maturing cannabis sector. Here's a primer on both.